Kintara Therapeutics Inc (KTRA)
0.1833
0.00 (0.00%)
USD |
NASDAQ |
Jun 14, 16:00
0.195
+0.01
(+6.38%)
Pre-Market: 09:17
Kintara Therapeutics Cash and Short Term Investments (Quarterly): 6.351M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.351M |
| December 31, 2023 | 0.658M |
| September 30, 2023 | 0.216M |
| June 30, 2023 | 1.535M |
| March 31, 2023 | 3.045M |
| December 31, 2022 | 4.874M |
| September 30, 2022 | 7.085M |
| June 30, 2022 | 11.78M |
| March 31, 2022 | 8.839M |
| December 31, 2021 | 14.06M |
| September 30, 2021 | 19.34M |
| June 30, 2021 | 10.54M |
| March 31, 2021 | 15.72M |
| December 31, 2020 | 17.16M |
| September 30, 2020 | 22.60M |
| June 30, 2020 | 2.392M |
| March 31, 2020 | 4.973M |
| December 31, 2019 | 6.348M |
| September 30, 2019 | 8.06M |
| June 30, 2019 | 3.719M |
| March 31, 2019 | 2.152M |
| December 31, 2018 | 3.703M |
| September 30, 2018 | 3.885M |
| June 30, 2018 | 5.972M |
| March 31, 2018 | 8.507M |
| Date | Value |
|---|---|
| December 31, 2017 | 11.02M |
| September 30, 2017 | 13.16M |
| June 30, 2017 | 6.586M |
| March 31, 2017 | 2.100M |
| December 31, 2016 | 3.417M |
| September 30, 2016 | 4.799M |
| June 30, 2016 | 6.157M |
| March 31, 2016 | 0.9374M |
| December 31, 2015 | 1.957M |
| September 30, 2015 | 2.804M |
| June 30, 2015 | 1.754M |
| March 31, 2015 | 3.007M |
| December 31, 2014 | 3.958M |
| September 30, 2014 | 4.316M |
| March 31, 2014 | 3.474M |
| December 31, 2013 | 4.137M |
| September 30, 2013 | 5.171M |
| June 30, 2013 | 6.283M |
| March 31, 2013 | 7.533M |
| December 31, 2012 | 0.004M |
| September 30, 2012 | 0.0006M |
| June 30, 2012 | 0.0018M |
| March 31, 2012 | 0.0028M |
| December 31, 2011 | 0.0008M |
| September 30, 2011 | 0.0068M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.216M
Minimum
Sep 2023
22.60M
Maximum
Sep 2020
8.465M
Average
6.718M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ARCA biopharma Inc | 35.90M |
| Vanda Pharmaceuticals Inc | 394.14M |
| Asensus Surgical Inc | 7.989M |
| Catalent Inc | 162.00M |
| CEL-SCI Corp | 5.309M |